BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33334899)

  • 1. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
    Hao D; He S; Harada K; Pizzi MP; Lu Y; Guan P; Chen L; Wang R; Zhang S; Sewastjanow-Silva M; Abdelhakeem A; Shanbhag N; Bhutani M; Han G; Lee JH; Zhao S; Weston B; Blum Murphy M; Waters R; Estrella JS; Roy-Chowdhuri S; Gan Q; Lee JS; Peng G; Hanash SM; Calin GA; Song X; Zhang J; Song S; Wang L; Ajani JA
    Gut; 2021 Nov; 70(11):2055-2065. PubMed ID: 33334899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
    Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
    Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomic landscape of oesophagogastric junctional adenocarcinoma.
    Chong IY; Cunningham D; Barber LJ; Campbell J; Chen L; Kozarewa I; Fenwick K; Assiotis I; Guettler S; Garcia-Murillas I; Awan S; Lambros M; Starling N; Wotherspoon A; Stamp G; Gonzalez-de-Castro D; Benson M; Chau I; Hulkki S; Nohadani M; Eltahir Z; Lemnrau A; Orr N; Rao S; Lord CJ; Ashworth A
    J Pathol; 2013 Nov; 231(3):301-10. PubMed ID: 24308032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.
    Geng Q; Lao J; Zuo X; Chen S; Bei JX; Xu D
    J Pathol; 2020 Nov; 252(3):263-273. PubMed ID: 32715475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.
    Maag JLV; Fisher OM; Levert-Mignon A; Kaczorowski DC; Thomas ML; Hussey DJ; Watson DI; Wettstein A; Bobryshev YV; Edwards M; Dinger ME; Lord RV
    Mol Cancer Res; 2017 Nov; 15(11):1558-1569. PubMed ID: 28751461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction.
    Lin Y; Luo Y; Sun Y; Guo W; Zhao X; Xi Y; Ma Y; Shao M; Tan W; Gao G; Wu C; Lin D
    Nat Commun; 2020 Nov; 11(1):6091. PubMed ID: 33257699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.
    Chen K; Yang D; Li X; Sun B; Song F; Cao W; Brat DJ; Gao Z; Li H; Liang H; Zhao Y; Zheng H; Li M; Buckner J; Patterson SD; Ye X; Reinhard C; Bhathena A; Joshi D; Mischel PS; Croce CM; Wang YM; Raghavakaimal S; Li H; Lu X; Pan Y; Chang H; Ba S; Luo L; Cavenee WK; Zhang W; Hao X
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1107-12. PubMed ID: 25583476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
    Liu Z; Wang A; Pu Y; Li Z; Xue R; Zhang C; Xiang X; E JY; Bu Z; Bai F; Ji J
    Oncogene; 2021 Sep; 40(38):5705-5717. PubMed ID: 34326469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonality analysis of synchronous gastro-oesophageal junction carcinoma and distal gastric cancer by whole-exome sequencing.
    Xing X; Jia S; Wu J; Feng Q; Dong B; Li B; Jia Y; Shan F; Li Y; Zhang Y; Hu Y; Wang X; Liu X; Yu W; Zhang L; Bu Z; Wu A; Li Z; Ji J
    J Pathol; 2017 Oct; 243(2):165-175. PubMed ID: 28671728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
    Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
    Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
    Pan HX; Bai HS; Guo Y; Cheng ZY
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
    Liao X; Xia X; Su W; Yan H; Ma Y; Xu L; Luo H; Liu W; Yin D; Zhang WH; Chen HN; Deng Y; Ren Z; Yu Z; Liao F; Chen K; Cao M; Zhang Y; Zhang W; Wang W; Zhao JN; Xu H; Shu Y
    Gynecol Oncol; 2022 Apr; 165(1):105-113. PubMed ID: 35151492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.
    Moss TJ; Qi Y; Xi L; Peng B; Kim TB; Ezzedine NE; Mosqueda ME; Guo CC; Czerniak BA; Ittmann M; Wheeler DA; Lerner SP; Matin SF
    Eur Urol; 2017 Oct; 72(4):641-649. PubMed ID: 28601352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
    Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
    Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
    Hu X; Wu L; Liu B; Chen K
    Front Immunol; 2021; 12():651056. PubMed ID: 34122409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic alterations in gastric cancers discovered via whole-exome sequencing.
    Zhang J; Qiu W; Liu H; Qian C; Liu D; Wang H; Hu N; Tang YT; Sun J; Shen Z
    BMC Cancer; 2018 Dec; 18(1):1270. PubMed ID: 30567531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
    Zengin T; Önal-Süzek T
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.
    Lin DC; Dinh HQ; Xie JJ; Mayakonda A; Silva TC; Jiang YY; Ding LW; He JZ; Xu XE; Hao JJ; Wang MR; Li C; Xu LY; Li EM; Berman BP; Phillip Koeffler H
    Gut; 2018 Oct; 67(10):1769-1779. PubMed ID: 28860350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy.
    M Naeini M; Newell F; Aoude LG; Bonazzi VF; Patel K; Lampe G; Koufariotis LT; Lakis V; Addala V; Kondrashova O; Johnston RL; Sharma S; Brosda S; Holmes O; Leonard C; Wood S; Xu Q; Thomas J; Walpole E; Tao Mai G; Ackland SP; Martin J; Burge M; Finch R; Karapetis CS; Shannon J; Nott L; Bohmer R; Wilson K; Barnes E; Zalcberg JR; Mark Smithers B; Simes J; Price T; Gebski V; Nones K; Watson DI; Pearson JV; Barbour AP; Waddell N
    Nat Commun; 2023 May; 14(1):3155. PubMed ID: 37258531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.